ART BIOSCIENCE
ART BioScience specializes in mRNA therapeutics for the treatment of rare diseases.
ART BIOSCIENCE
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2015-12-01
Address:
Rehovot, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.artbioscience.com
Total Employee:
11+
Status:
Active
Contact:
972-8-623-7879
Email Addresses:
[email protected]
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Dimension Therapeutics
Dimension Therapeutics is a gene therapy company developing novel treatments for rare diseases.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Inno Medicine
Inno Medicine specializes in research on the pathogenesis of atherosclerosis.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Stabiliz Orthopaedics
Stabiliz Orthopaedics develops novel enhancements for orthopedic medical devices using FDA-approved technologies.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Official Site Inspections
http://www.artbioscience.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "ART BioScience"
About Us - ART Bioscience
ART BioScience was founded in December 2015 by Mr. Oren Ozeri and Mr. Alon Hazan, fathers of two children diagnosed with Duchenne. After co-founding the Israeli Duchenne Parent Association and increased involvement in following …See details»
Leadership - ART Bioscience
Raanan Margalit founded Science in Action - a boutique preclinical CRO in 2010 after over 25 years of scientific practice in Academia and industry, where he gained knowledge and experience in immunology, cell biology, …See details»
ART BioScience - Crunchbase Company Profile & Funding
Organization. ART BioScience . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 972-8 …See details»
Art Bioscience Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Www.artbioscience.com. Startups | Private Company | 2015 | Israel | 10-50 | www.artbioscience.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
ART BioScience Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for ART BioScience. Use the PitchBook Platform to explore the full profile.See details»
Genetic Therapies for Duchenne Muscular Dystrophy
Apr 12, 2021 ART BioScience specializes in the use of novel messenger RNA technologies for the development of therapeutics that may potentially change the course of Duchenne Muscular Dystrophy.See details»
Company: ART Bioscience
ART Bioscience is a pre-clinical stage biotechnology company focused on developing mRNA-based therapies for rare diseases, with a primary focus on duchenne muscular dystrophy (DMD).See details»
ART BioScience - VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»
ARTBIO - Leadership Team - The Org
The Leadership Team at ARTBIO is responsible for steering the company’s strategic vision and operational execution. This team, comprised of key executives including the CEO, Vice …See details»
Contact Us - ART Bioscience
If you are interested in a partnering with Art Bioscience to push forward developments for those impacted by rare and debilitating DMD diseases, please contact us at [email protected] Phone: +972-8-623-7879See details»
Art BioScience | Cure Orphan diseases, Duchenne Muscular Dys
Art BioScience Pioneering mRNA Therapeutics for the Treatment of Rare DiseasesSee details»
Artbio Company Profile - Office Locations, Competitors, Revenue …
Artbio has 5 employees across 4 locations and $90 m in total funding,. See insights on Artbio including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
ARTBIO
ARTBIO is shaped by a long-standing scientific legacy with nearly a century of pioneering work in radiation therapy. Born out of groundbreaking research conducted at the University of Oslo …See details»
Our Science | ART Bioscience
Art Bioscience is a pre-clinical biopharma company focused on finding genetic therapies for Duchenne muscular dystrophy (DMD) that meet the diversity and unmet needs of the patient …See details»
Artbio launches for alpha-emitting therapies
Jul 3, 2023 Artbio , a start-up with a focus on developing radiopharmaceuticals to treat cancer , pulls its name right from its medicines—alpha radioligand therapies (ART). The nascent firm, …See details»
ARTBIO Company Profile: Overview and Full News Analysis
ARTBIO, based in Massachusetts, is a pioneering company redefining cancer care through the development of alpha radioligand therapies (ART) and the creation of an ecosystem to …See details»
Career | ART Bioscience
Join Art Bioscience mission today. We are an equal opportunity employer. Applicants and employees are considered for positions and are evaluated without regard to mental or physical …See details»
Investors pour $90M onto ARTBIO's palette 6 months after launch
Dec 7, 2023 ARTBIO has closed a $90 million series A less than six months after launch. The round was led by Third Rock Ventures and a healthcare fund.See details»
Pipeline - ART Bioscience
We are advancing innovative mRNA genetic therapeutics for Duchenne Muscular Dystrophy using our proprietary Nano Lipid Particles delivery system.See details»